BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3486674)

  • 1. Helical conformation at the carboxy-terminal portion of human C3a is required for full activity.
    Hoeprich PD; Hugli TE
    Biochemistry; 1986 Apr; 25(8):1945-50. PubMed ID: 3486674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peptide.
    Lu ZX; Fok KF; Erickson BW; Hugli TE
    J Biol Chem; 1984 Jun; 259(12):7367-70. PubMed ID: 6610676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The active site of human C4a anaphylatoxin.
    Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
    Hugli TE; Erickson BW
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The active site of C3a anaphylatoxin.
    Caporale LH; Tippett PS; Erickson BW; Hugli TE
    J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
    Fernandez HN; Hugli TE
    J Biol Chem; 1978 Oct; 253(19):6955-64. PubMed ID: 690134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues.
    Unson CG; Erickson BW; Hugli TE
    Biochemistry; 1984 Feb; 23(4):585-9. PubMed ID: 6608957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function studies of analogues of parathyroid hormone (PTH)-1-34 containing beta-amino acid residues in positions 11-13.
    Peggion E; Mammi S; Schievano E; Silvestri L; Schiebler L; Bisello A; Rosenblatt M; Chorev M
    Biochemistry; 2002 Jun; 41(25):8162-75. PubMed ID: 12069609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton nuclear magnetic resonance study of the third component of complement: solution conformation of the carboxyl-terminal segment of C3a fragment.
    Muto Y; Fukumoto Y; Arata Y
    Biochemistry; 1985 Nov; 24(23):6659-65. PubMed ID: 3878728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The primary structure of porcine C3a anaphylatoxin.
    Corbin NC; Hugli TE
    J Immunol; 1976 Sep; 117(3):990-5. PubMed ID: 956663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing synthetic superagonists of C3a anaphylatoxin.
    Ember JA; Johansen NL; Hugli TE
    Biochemistry; 1991 Apr; 30(15):3603-12. PubMed ID: 2015217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and partial characterization of human and porcine C3a anaphylatoxin.
    Hugli TE; Vallota EH; Müller-Eberhard HJ
    J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution conformation of carboxy-terminal fragments of the third component of human complement C3: proton nuclear magnetic resonance study of C3a, des-Arg-C3a, and C3a Arg69.
    Muto Y; Fukumoto Y; Arata Y
    J Biochem; 1987 Sep; 102(3):635-41. PubMed ID: 3501427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemistry and biology of anaphylatoxins.
    Hugli TE
    Complement; 1986; 3(3):111-27. PubMed ID: 3542363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function of the anaphylatoxins.
    Hugli TE
    Springer Semin Immunopathol; 1984; 7(2-3):193-219. PubMed ID: 6387982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human anaphylatoxin (C3a) from the third component of complement. Primary structure.
    Hugli TE
    J Biol Chem; 1975 Nov; 250(21):8293-301. PubMed ID: 1238393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraction of guinea pig lung by synthetic oligopeptides related to human C3a.
    Huey R; Erickson BW; Bloor CM; Hugli TE
    Immunopharmacology; 1984 Aug; 8(1):37-45. PubMed ID: 6333413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human C4a anaphylatoxin.
    Gorski JP; Hugli TE; Müller-Eberhard HJ
    J Biol Chem; 1981 Mar; 256(6):2707-11. PubMed ID: 6970745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denaturation and unfolding of human anaphylatoxin C3a: an unusually low covalent stability of its native disulfide bonds.
    Chang JY; Lin CC; Salamanca S; Pangburn MK; Wetsel RA
    Arch Biochem Biophys; 2008 Dec; 480(2):104-10. PubMed ID: 18854167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic disulfide analogues of the complement component C3a. Synthesis and conformational investigations.
    Pohl M; Ambrosius D; Grötzinger J; Kretzschmar T; Saunders D; Wollmer A; Brandenburg D; Bitter-Suermann D; Höcker H
    Int J Pept Protein Res; 1993 Apr; 41(4):362-75. PubMed ID: 8496018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.